David P. Luci's Insider Trades & SAST Disclosures

David P. Luci's most recent trade in Acurx Pharmaceuticals Inc was a trade of 250,000 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 250,000 250,000 - - Stock Option
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jan 2025 49,261 49,261 - - Warrants for Common Stock
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.02 per share. 06 Jan 2025 49,261 1,097,458 - 1.0 50,000 Common Stock
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2024 250,000 250,000 - - Stock Option
Acurx Pharmaceuticals Inc
Luci P. David Director, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2024 19,737 0 - - Warrants for Common Stock
Acurx Pharmaceuticals Inc
P. David Luci Director, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. 03 Jan 2024 19,737 1,048,197 - 3.5 70,066 Common Stock
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.80 per share. 19 Nov 2021 5,200 1,008,723 - 4.8 24,960 Common Stock
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 500,000 500,000 - - Stock Option
Acurx Pharmaceuticals Inc
David P. Luci Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 350,000 350,000 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades